Phase 2 study evaluating PPS efficacy and safety in MPS VILikeFollowShareSource: Giugliani R, et alFebruary 24, 2023Share your feedbackQuestions (0)Post questionYour question will be sent privately to Paradigm Biopharmaceuticals. The company may choose to make this question public.Start the conversationAsk Paradigm Biopharmaceuticals a question about this update.Discover
